Stephanie Saw, Medical Oncologist at National Cancer Center of Singapore, shared a post on X:
“Inspired by my good friend and slide master Jordi Remon – sharing these updated summary slides for 1L and post-progression treatment options for advanced stage EGFR-mutated NSCLC.
Might be outdated soon but hopefully not before 2025.”
